These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner. Li X, Du X, Huo T, Liu X, Zhang S, Yuan F. Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236 [Abstract] [Full Text] [Related]
5. Impact of surface coating and particle size on the uptake of small and ultrasmall superparamagnetic iron oxide nanoparticles by macrophages. Saito S, Tsugeno M, Koto D, Mori Y, Yoshioka Y, Nohara S, Murase K. Int J Nanomedicine; 2012 Jul; 7():5415-21. PubMed ID: 23091384 [Abstract] [Full Text] [Related]
6. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging. Khandhar AP, Wilson GJ, Kaul MG, Salamon J, Jung C, Krishnan KM. J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208 [Abstract] [Full Text] [Related]
7. Peptide-Decorated Ultrasmall Superparamagnetic Nanoparticles as Active Targeting MRI Contrast Agents for Ovarian Tumors. Yin J, Yao D, Yin G, Huang Z, Pu X. ACS Appl Mater Interfaces; 2019 Nov 06; 11(44):41038-41050. PubMed ID: 31618000 [Abstract] [Full Text] [Related]
8. [Labeling of mesenchymal stem cells with different superparamagnetic particles of iron oxide and detectability with MRI at 3T]. Ittrich H, Lange C, Dahnke H, Zander AR, Adam G, Nolte-Ernsting C. Rofo; 2005 Aug 06; 177(8):1151-63. PubMed ID: 16021549 [Abstract] [Full Text] [Related]
9. Ultrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes. Frascione D, Diwoky C, Almer G, Opriessnig P, Vonach C, Gradauer K, Leitinger G, Mangge H, Stollberger R, Prassl R. Int J Nanomedicine; 2012 Aug 06; 7():2349-59. PubMed ID: 22661890 [Abstract] [Full Text] [Related]